IFNG and HIV-1 infection: Preliminary data from patients with HIV-1 infection suggest that IFN-γ might enhance vaccine-induced IgG2 antibodies to HIV-1 Gag proteins [96], and this potential approach to therapeutic vaccination should be considered further.